Pål Ryfors will remain as interim Chief Financial Officer and the Board wishes to have a close co-operation with him also going forward.

“We are pleased that Katarina Flodström has accepted the position as Chief Executive Officer. Katarina has been with the company since its inception and possesses deep knowledge of both the company and its technology. I would like to extend my gratitude to Pål for his long-standing service as CEO. He has played an important role in taking the company to the U.S. market, which has been a key strategic objective, and he has implemented a number of strategic transformation programs that have resulted in Episurf becoming a more streamlined company with distributor partners worldwide. It is entirely understandable that he now wishes to pursue a new role, and we look forward to continued collaboration with him,” says Ulf Grunander, Chairman of the Board of Directors, Episurf Medical.

Katarina Flodström

Katarina Flodström, born in 1975, has a PhD in Physical Chemistry from Lund University and an MSc in Chemical Engineering from the Royal Institute of Technology in Stockholm. She has been employed at different positions at Episurf Medical since 2014 and has been part of the management team since 2018. The change will take effect on October 1.

“I am grateful for the opportunity to assume the role of CEO of Episurf Medical. We have important regulatory and commercial initiatives underway, and I look forward to driving these forward with full force,” says Katarina Flodström, incoming Chief Executive Officer, Episurf Medical.